Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a year ago

Possible Interaction: Cannabidiol and Marijuana

supplement:

Cannabidiol

supplement:

Marijuana

Research Papers that Mention the Interaction

Compared with placebo, cannabidiol 400 mg decreased THC-COOH:creatinine ratio by -94·21 ng/mL (95% interval estimate -161·83 to -35·56) and increased abstinence from cannabis by 0·48 days per week (0·15 to 0·82).
Compared with placebo, cannabidiol 800 mg decreased THC-COOH:creatinine ratio by -72·02 ng/mL (-135·47 to -19·52) and increased abstinence from cannabis by 0·27 days per week (-0·09 to 0·64).
The lancet. Psychiatry  •  2020  |  View Paper
It is quite possible that cannabidiol , licensed in the USA for treating rare genetic epilepsies, may open the door for the widespread legalisation of recreational cannabis.
Practical Neurology  •  2018  |  View Paper
CBD may have therapeutic potential for the treatment of psychosis following cannabis use , as well as schizophrenia, possibly with better tolerability than current antipsychotic treatments.
Neurotherapeutics  •  2015  |  View Paper
The high degree of interindividual variability in the responses to cannabis is contributed by a wide spectrum of factors, including genetic and environmental determinants, as well as differences in the relative concentrations of THC and other alkaloids (such as cannabidiol ) within the plant itself.
Recent patents on CNS drug discovery  •  2012  |  View Paper
Marijuana and its constitutive cannabinoids--tetrahydrocannabinol (THC), cannabinol (CBN), and cannabidiol (CBD)--markedly affect mammalian cells.
The International journal of the addictions  •  1990  |  View Paper
Abstract Background: Ratios of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) impact metabolism and therapeutic effects of cannabis.
Substance use & misuse  •  2020  |  View Paper
RESULTS Depression, anxiety and cognition significantly worsened as the reported percentage of CB , T HC and overall frequency of can nabis use in the past 30 days increased.
Pain management nursing : official journal of the American Society of Pain Management Nurses  •  2019  |  View Paper
Frequent cannabis users may show a blunted anti- psychotic response to CBD , which is of concern due to the high rates of cannabis use disorders in patients with schizophrenia.
Translational Psychiatry  •  2018  |  View Paper
Cannabidiol (CBD) is not psychoactive but plays a modulating role on cannabis psychoactive effects.
Adicciones  •  2018  |  View Paper
Finally, cannabis smoke contains various cannabinoids, for example cannabidiol which also have anti-inflammatory and antifibrotic properties, with the unconfirmed hypothesis that these properties can partially modulate the deleterious action of cannabis smoke.
Revue de pneumologie clinique  •  2017  |  View Paper
Show More